BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 23235576)

  • 1. Ursodeoxycholic acid for primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD000551. PubMed ID: 23235576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitazoxanide for chronic hepatitis C.
    Nikolova K; Gluud C; Grevstad B; Jakobsen JC
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD009182. PubMed ID: 24706397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis.
    Simonetti RG; Perricone G; Nikolova D; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004039. PubMed ID: 31251387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011451. PubMed ID: 30610762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.
    Hauser G; Awad T; Brok J; Thorlund K; Štimac D; Mabrouk M; Gluud C; Gluud LL
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005441. PubMed ID: 24585509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B.
    Liang N; Kong Z; Ma SS; Lu CL; Yang M; Feng LD; Shen C; Diao RH; Cui LJ; Lu XY; Nikolova D; Jakobsen JC; Gluud C; Liu JP
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD013089. PubMed ID: 30941748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman O; Elsayed Z
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011313. PubMed ID: 31978267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.
    Vadera S; Yong CWK; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012673. PubMed ID: 31220333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure.
    Siu JT; Nguyen T; Turgeon RD
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012123. PubMed ID: 33294991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D supplementation for chronic liver diseases in adults.
    Bjelakovic M; Nikolova D; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011564. PubMed ID: 34431511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C.
    Hauser G; Awad T; Thorlund K; Štimac D; Mabrouk M; Gluud C
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005642. PubMed ID: 24585451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
    Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticosteroids for people with alcoholic hepatitis.
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001511. PubMed ID: 30964545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B.
    Liang N; Kong Z; Lu CL; Ma SS; Li YQ; Nikolova D; Jakobsen JC; Gluud C; Liu JP
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD013106. PubMed ID: 31232459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citicoline for treating people with acute ischemic stroke.
    Martí-Carvajal AJ; Valli C; Martí-Amarista CE; Solà I; Martí-Fàbregas J; Bonfill Cosp X
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013066. PubMed ID: 32860632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
    Khakoo NS; Sultan S; Reynolds JM; Levy C
    Dig Dis Sci; 2023 Apr; 68(4):1559-1573. PubMed ID: 36180756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocoagulation for liver metastases.
    Storman D; Swierz MJ; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD009497. PubMed ID: 33507555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical exercise for people with cirrhosis.
    Aamann L; Dam G; Rinnov AR; Vilstrup H; Gluud LL
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012678. PubMed ID: 30575956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.